Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 11, 2026 03:30 ET | Source: Scenic Biotech

Scenic Biotech Joins Michael J. Fox Foundation’s LITE Program to Explore New Disease-Modifying Approach for Parkinson's Disease

Scenic Biotech Joins Michael J. Fox Foundation’s LITE Program to Explore New Disease-Modifying Approach for Parkinson's Disease
June 11, 2026 01:00 ET | Source: F. Hoffmann-La Roche Ltd

FDA grants Priority Review for Roche’s Tecentriq for a certain type of stage III colon cancer

Filing acceptance is based on the phase III Alliance ATOMIC study showing Tecentriq plus chemotherapy reduced recurrence or death risk by 50% versus chemotherapy alone1Nearly one in three patients...
June 10, 2026 18:55 ET | Source: TermPlus

TermPlus Fixed-Term Accounts Deliver Monthly Income for some of Australia's 4.4 Million Retirees and 663,867 SMSFs - June 2026 Five-Year Target Rate 8.50%* Per Annum

Sydney, Australia, June 10, 2026 (GLOBE NEWSWIRE) -- Australians planning for retirement income face two converging trends. Around 4.4 million Australians are now aged 65 and over, about 17% of the...
June 10, 2026 09:15 ET | Source: MAIA Biotechnology, Inc.

MAIA Biotechnology Activates and Opens Enrollment at Second U.S. Clinical Site for International Phase 2 THIO-101 Expansion Trial

Additional data from MAIA’s THIO-101 expansion may further support an accelerated approval filing with the FDA Potential breakthrough therapy holds substantial commercial opportunity in a projected...
June 10, 2026 06:00 ET | Source: NorthWest Copper Corp.

NorthWest Reports Palladium Assay Results at Kwanika, Highlighting Potential for a By-Product Credit

TORONTO, June 10, 2026 (GLOBE NEWSWIRE) -- NorthWest Copper Corp. (“NorthWest” or the “Company”) (TSX-V: NWST) reports palladium assay results from stored sample pulps collected from historical...
June 09, 2026 13:35 ET | Source: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN). Such...
June 09, 2026 09:00 ET | Source: Red Rover Technologies LLC

Red Rover Accelerates Growth as K-12 Districts Seek Modern Workforce Management Solutions to Overcome Operational Complexities

EXTON, Pa., June 09, 2026 (GLOBE NEWSWIRE) -- Red Rover, the fastest-growing provider of human capital management (HCM) solutions for K-12 education, today announced significant milestones marked by...
June 09, 2026 02:06 ET | Source: Harness Therapeutics

Harness Therapeutics Awarded Grant from The Michael J. Fox Foundation for Parkinson’s Research to Advance Parkinson's Disease Programme

Grant awarded through the Parkinson's Disease Therapeutics Pipeline Program to support advancement of Harness' new programme targeting GCase and LIMP2 for Parkinson's disease Two-year programme...
June 08, 2026 13:15 ET | Source: Vantive

Vantive Highlights Late-Breaking High Clinical Impact Data at ERA Indicating HDx Therapy is a Practical Alternative to Online Hemodiafiltration

The MOTheR and CONCORDIA studies show HDx therapy (expanded hemodialysis) enabled by the Theranova dialyzer delivers outcomes comparable to online hemodiafiltrationTheranova dialyzer’s unique design...
June 08, 2026 08:33 ET | Source: AIM ImmunoTech Inc.

AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

OCALA, Fla., June 08, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today reported positive progress in a mid-year update from the ongoing Phase 2...